Esperion Therapeutics, Inc.ESPRNASDAQ
Loading
P/E Ratio: Discounted ValuationCompressed
Percentile Rank0
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-33.91
↓ 292% vs avg
Percentile
P0
Near historical low
Streak
2 yr
Consecutive declineCompressed
Average
-8.65
Historical baseline
PeriodValueYoY Change
2025-33.91-326.1%
2024-7.96-440.2%
2023-1.47+16.8%
2022-1.77-229.7%
2021-0.54+89.2%
2020-4.98+70.1%
2019-16.63-172.6%
2018-6.10+35.4%
2017-9.44-150.7%
2016-3.76-